Facilitation of HIV-1 isolation from patients by neuraminidase

Archives of Virology

Volumn 143, Issue 1, 1998, Pages 85-95

  Xin, X ^a   Shioda, T ^a   Fukushima, M ^b   Hu, H ^a   Oka, S ^a   Iwamoto, A ^a   Nagai, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD; CHILD; COMPARATIVE STUDY; DRUG EFFECT; ENVELOPE GENE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MOLECULAR GENETICS; MONONUCLEAR CELL; SEQUENCE HOMOLOGY; STANDARD; TIME; VIROLOGY; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; FEMALE; GENES, ENV; HIV SEROPOSITIVITY; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; RNA, VIRAL; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031883668     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050270     Document Type: Article

References (29)

1. Bernstein HB, Tucker SP, Hunter E, Schutzbach JS, Compans PW (1994) Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol 68: 463-468
2. Boom R, Sol CGA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, Van Der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503
3. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1α, and MIP-1β as the major. HIV-suppressive factors produced by CD8+ T cells. Science 270: 1 811-1 815
4. Domingo E, Salas EM, Sobrio F, de la Torre JC, Portela A, Ortin J, López-Galindez C, Pérez-Breńa P, Villanueva N, Nájera R, VandePol S, Steinhau O, DePolo N, Holland J (1985) The quasispecies (extremely heterologous) nature of viral RNA genome populations: biological relevance - a review. Gene 40: 1-18
5. Feizi T, Larkin M (1990) AIDS and glycosylation. Glycobiology 1: 17-23
6. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S (1989) HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 2: 344-352
7. Groenink M, Fouchier RAM, Broersen S, Baker CH, Koot M, Van't Weut AB, Huisman HF, Miedema F, Tersmette M, Schuitemaker H (1993) Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science. 260: 1 513-1 516
8. Geyer H, Holschbach C, Hunsmann G, Schneider J (1988) Carbohydrates of human immunodeficiency virus. J Biol Chem 263: 1 1760-1 1767
9. Hollinger FB, Bremer JW, Myers LE, Gold JWM, Mcquay L, The NIH/NIAID/DAIDS/ACTG Virology Laboratories (1992) Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical trials group. J Clin Microbiol 30: 1 787-1 794
10. Hu H, Shioda T, Moriya C, Xin X, Hasan MK, Miyake K, Shimada T, Nagai Y (1996) Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J Virol 70: 7 462- 7 470
11. Kannagi M, Matsuda T, Hatori T, Kanoh T, Nasu K, Yamanoto N, Harada S (1990) Interference with human immunodeficiency virus (HIV) replication by CD8+ T-cell in peripheral blood leukocytes of asymptomatic carriers in vitro. J Virol 64: 3 399-3406
12. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosyla-tion sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovarycells. J Biol Chem 265: 10373-10382
13. Manca F (1992) Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J Immunol 148: 2 278-2 282
14. Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky T, Morfeldt-Manson L, Asjö B, Wain-Hobson S (1989) Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58: 901-910
15. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T (1988) Carbohydrate structures of the human-immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J 254: 599-630
16. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T (1988) Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biomed Chromatogr 2: 260-270
17. Montefiori DC, Stewart K, Ahearn JM, Zhou J, Zhou J (1993) Complement-mediated binding of naturally glycosylated and glycosylation- modified human immunodeficiency virus type 1 to human CR2 (CD21). J Virol 67: 2 699-2 706
18. Oka S, Ida S, Shioda T, Takebe Y, Kobayashi N, Shibuya Y, Ohyama K, Monota K, Kimura S, Shimada K (1994) Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. AIDS Res Hum Retroviruses 10: 271-277
19. Shioda T, Oka S, Ida S, Nokihara K, Toriyoshi J, Mori S, Takebe Y, Kimura S, Shimada K, Nagai Y (1994) A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J Virol 68: 7 689-7 696
20. Shioda T, Oka S, Xin X, Liu H, Harukuni R, Kurotani A, Fukushima M, Hasan MK, Shiino T, Takebe Y, Iwanoto A, Nagai Y (1997) In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression. J Virol 71: 4 871-4 881
21. Stein BS, Engleman EG (1990) Intracellular processing of the gp160 HIV-1 envelope precursor. J Biol Chem 265: 2 640-2 649
22. Sullivan N, Thali M, Furman C, Ho DD, Sodroski J (1993) Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J Virol 67: 3 674-3 679
23. Tateno Y, Tateno M, Ikuta K, Yoshiki T, Togashi T, Matsumoto S (1994) Genetic and functional variabilities in the human immunodeficiency virus type 1 isolated from the same blood samples with and without CD8+ cells. Immunol Infect Dis 4: 41-46
24. Tsubota H, Lord CI, Watkins DI, Morimoto D, Letvin NL (1989) A cytotoxic T-lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 169: 1 421-1 434
25. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT (1987) HIV-specific cytotoxic T-lymphocytes in seropositive individuals. Nature 328: 345-348
26. Walker CM, Moody DJ, Stites DP, Levy JA (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1 563-1 566
27. Weiss RA (1993) How does HIV cause AIDS? Science 260: 1 273- 1 279
28. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA (1988) In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139-147
29. Williams LM, Cloyd MW (1991) Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184: 723-728